-45.28 (-0.71%)
0.80 (+1.34%)| 5-Day | 279,558 |
| 10-Day | 185,869 |
| 30-Day | 115,843 |
| 5-Day | 279,558 |
| 10-Day | 185,869 |
| 30-Day | 115,843 |
0.70 (+1.17%)| 5-Day | 604,891 |
| 10-Day | 424,170 |
| 30-Day | 259,999 |
| 5-Day | 604,891 |
| 10-Day | 424,170 |
| 30-Day | 259,999 |
COLLAPSE ALL| Days | BSE | NSE |
| 30 | 42.69 | 42.74 |
| 50 | 41.98 | 42.00 |
| 150 | 60.12 | 60.08 |
| 200 | 68.77 | 68.71 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dishman Pharma
| (Sep '11) Quarterly |
(Mar '11) Yearly |
|
| Net Sales | 107.69 | 419.57 |
| Other Income | 0.00 | 0.00 |
| PBDIT | 13.96 | 165.31 |
| Net Profit | -3.59 | 40.13 |
| Total Share Capital | 16.14 |
| Net Worth | 641.38 |
| Total Debt | 561.67 |
| Net Block | 486.78 |
| Investments | 187.14 |
| Net Current Assets | 225.51 |
| Total Assets | 1203.04 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 541.30 | -0.12 | 565.75 | 404.00 | 56,056.05 |
| Cipla | 349.00 | -0.78 | 359.00 | 273.60 | 28,021.96 |
| Dr Reddys Labs | 1619.85 | -1.19 | 1716.00 | 1387.00 | 27,463.59 |
| Lupin | 458.80 | -2.90 | 492.00 | 363.00 | 20,491.02 |
| Ranbaxy Labs | 443.30 | -1.83 | 570.00 | 366.50 | 18,708.66 |
| More » | |||||
| Sep' 11 | Jun' 11 | Mar' 11 | Dec' 10 | |
| Promoter | 61.20 | 61.20 | 61.20 | 60.90 |
| FII | 6.11 | 7.69 | 8.08 | 8.64 |
| DII | 7.02 | 7.92 | 8.48 | 9.34 |
| Others | 25.67 | 23.19 | 22.24 | 21.12 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| SBI Magnum Tax Gain Scheme (G) | 750,240 |
| UTI Mahila Unit Scheme (G) | 101,465 |
| Canara Robeco Emerging Equities (G) | 72,279 |
|
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Tata Steel | Vodafone Essar | Standard and Poor's | Aurobindo Pharma | Namma Metro | Mahindra Satyam | Iran | Reliance Industries | Britannia Industries